Cargando…
Correction: EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features
Autores principales: | Li, Feng, Liu, Yongmei, Chen, Huijiao, Liao, Dianying, Shen, Yali, Xu, Feng, Wang, Jin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070668/ http://dx.doi.org/10.1186/1756-9966-30-32 |
Ejemplares similares
-
EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features
por: Li, Feng, et al.
Publicado: (2011) -
Correction: Potential benefit of osimertinib plus bevacizumab in leptomeningeal metastasis with EGFR mutant non-small-cell lung cancer
por: Yi, Yali, et al.
Publicado: (2022) -
Correction: Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR / ALK wild-type advanced non-small cell lung cancer
Publicado: (2020) -
Correction: EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCR
por: Madic, Jordan, et al.
Publicado: (2019) -
Correction: Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR-Mutated Non–Small Cell Lung Cancer
Publicado: (2022)